Integra LifeSciences Company Insiders

Integra LifeSciences Management Team Effectiveness

The company has return on total asset (ROA) of 0.0266 % which means that it generated a profit of $0.0266 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0186) %, meaning that it created substantial loss on money invested by shareholders. Integra LifeSciences' management efficiency ratios could be used to measure how well Integra LifeSciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.01 in 2025, whereas Return On Tangible Assets are likely to drop (0) in 2025. Total Current Liabilities is likely to gain to about 968.2 M in 2025. Liabilities And Stockholders Equity is likely to gain to about 4.2 B in 2025Net Income Applicable To Common Shares is likely to gain to about 218 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 67.8 M in 2025.

Integra LifeSciences Workforce Comparison

Integra LifeSciences Profit Margins

The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.

Integra LifeSciences Insider Trading History

Integra LifeSciences Notable Stakeholders

The success or failure of an entity such as Integra LifeSciences often depends on how effective the management is. Integra LifeSciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Integra management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Integra management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Integra LifeSciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Integra LifeSciences Holdings. Check Integra LifeSciences' Beneish M Score to see the likelihood of Integra LifeSciences' management manipulating its earnings.

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.